The Supreme Court on Monday rejected an appeal by a drug maker over a judge's ruling that information Pfizer withheld during a Lipitor patent case was immaterial.
April 03, 2007 at 12:00 AM
1 minute read
The original version of this story was published on National Law Journal
The Supreme Court on Monday rejected an appeal by a drug maker over a judge’s ruling that information Pfizer withheld during a Lipitor patent case was immaterial.
Ranbaxy Laboratories Ltd. had asked the justices to hear the case, which involves patents of Lipitor manufacturer Pfizer Inc. for the drug used to treat high cholesterol.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
